UPDATED: GlaxoSmithKline measures 36-meter leap over placebo in Duchenne walking test

John Carroll GlaxoSmithKline investigator John Kraus reviewed the long-awaited mid-stage results for its Duchenne muscular dystrophy drug drisapersen this afternoon, revealing that ...
Page 7 of 7« First...34567
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS